Role of extracorporeal photopheresis in the management of children with graft-vs-host disease.
Pedro AsensiJaime Sanz CaballerCarolina Fuentes SocorroPilar Solves AlcaínaPilar Lloret MadridJürgen Solís RuízBárbara Torres GuerolaJavier de la Rubia ComosJosé María Fernández NavarroInes Gómez-SeguíPublished in: Journal of clinical apheresis (2022)
ECP is feasible, safe, and effective for pediatric patients with corticorefractory or corticodependant GVHD, offering a less toxic and nonimmunosuppressive treatment option.